Nobel Prize 2024: Victor Ambros and Gary Ruvkun Win 2024 Nobel Prize for Breakthrough in Gene Regulation

The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNAs and their pivotal role in regulating gene activity after transcription. This revolutionary finding unveiled a novel mechanism of gene regulation essential for the growth, development, and functioning of multicellular organisms, including humans. By identifying and clarifying the function of microRNAs, Ambros and Ruvkun have made significant strides in our understanding of genetic regulation, an area with vast implications for tackling diseases such as cancer, diabetes, and autoimmune disorders.

Announced by Sweden's Karolinska Institute, this year's Nobel Prize recognizes the importance of microRNAs, tiny RNA molecules that profoundly influence gene regulation. "This year's Nobel Prize in Physiology or Medicine honors two scientists for discovering a fundamental principle of how gene activity is controlled. They discovered microRNA, a new class of small RNA molecules crucial for gene regulation," stated the institute. Their discovery marks a monumental leap in the biological sciences, shedding light on a previously unknown way our cells control genetic information.

Gene regulation lies at the heart of cellular function, allowing cells to selectively turn genes on or off depending on their needs. Although all cells within an organism contain identical genetic material, gene regulation ensures that different cells perform specific functions by activating or suppressing certain genes. For instance, muscle cells and nerve cells differ not because they have different genes but because they express a different subset of their common genes. The pioneering work of Ambros and Ruvkun has been instrumental in unraveling how microRNAs influence these regulatory processes, providing crucial insights into cellular differentiation and function.

Established by Alfred Nobel, the Nobel Prize in Physiology or Medicine is one of the earliest categories of the prize. Since its inception in 1901, the prize has been awarded 114 times, recognizing the exceptional contributions of over 227 individuals. Thirteen of these recipients have been women, highlighting the increasing diversity among laureates. The prize has also honored recipients from a wide range of ages, from Frederick G. Banting, the youngest at 31 for his discovery of insulin, to Peyton Rous, the oldest at 87 for his work on tumor-inducing viruses. One notable laureate is India-born Har Gobind Khorana, who won the Nobel Prize in 1968 for his groundbreaking research on the genetic code.

The Nobel Prize, founded by Alfred Nobel, is among the most prestigious global honors, celebrating outstanding achievements in Physics, Chemistry, Literature, Peace, Economics, and Physiology or Medicine. With a prize fund of approximately $1 million (11 million Swedish crowns), the Nobel Prize represents Nobel's vision of honoring those whose work benefits humanity. Each year, the Nobel Prize in Physiology or Medicine is announced by the Karolinska Institute, which plays a crucial role in selecting the laureates. The awards are traditionally presented on December 10, commemorating Nobel's death, in recognition of the enduring impact of the laureates' discoveries.

The recognition of Ambros and Ruvkun's work in the 2024 Nobel Prize underscores the immense significance of their discovery of microRNAs in the field of gene regulation. Their contribution has not only expanded our understanding of genetic processes but has also opened up new paths for medical research and potential therapies for numerous diseases. By continuing to honor groundbreaking discoveries, the Nobel Prize remains a testament to Alfred Nobel's vision of advancing human knowledge and improving lives globally.